MedPath

Sildenafil on Improving Chronic Lung Disease of neonates

Phase 3
Conditions
Chronic lung disease of newborns.
Newborn (suspected to be) affected by other maternal circulatory and respiratory diseases
P00.3
Registration Number
IRCT20160102025811N4
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Chronic pulmonary disease based on oxygen demand in 36 weeks of intrauterine age
Infant hemodynamic stability
Absence of gastrointestinal disorders
Written consent of the patient's parents to participate in the study

Exclusion Criteria

Parents 'dissatisfaction with patients' participation in the study
The need for oxygen during the 36 weeks of intrauterine age is known due to chronic lung disease
Hemodynamic instability
Nutritional intolerance

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fio2. Timepoint: daily. Method of measurement: Oxymetric pulse and heart monitoring.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath